SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-072859
Filing Date
2012-11-01
Accepted
2012-11-01 06:01:41
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-19899_110q.htm 10-Q 1514841
2 EX-10.1 a12-19899_1ex10d1.htm EX-10.1 4193
3 EX-31.1 a12-19899_1ex31d1.htm EX-31.1 14429
4 EX-31.2 a12-19899_1ex31d2.htm EX-31.2 14364
5 EX-32.1 a12-19899_1ex32d1.htm EX-32.1 7907
6 EX-32.2 a12-19899_1ex32d2.htm EX-32.2 7852
  Complete submission text file 0001104659-12-072859.txt   12840195

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT uthr-20120930.xml EX-101.INS 1833211
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20120930.xsd EX-101.SCH 121068
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20120930_cal.xml EX-101.CAL 94955
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20120930_def.xml EX-101.DEF 592339
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20120930_lab.xml EX-101.LAB 1986645
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20120930_pre.xml EX-101.PRE 873081
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 121172010
SIC: 2834 Pharmaceutical Preparations